AKT1 and cancer: Consistent with previous reports17–19, PI3K-AKT signaling pathway was enriched in both primary tumors and BMs (q = 8.19 × 10−8, q = 9.78 × 10−13, respectively), which is confirmatory of its universal role in cancer progression11.